QA: Akorn INC in us_pharma/2019

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000003116_2020_Akorn_INC.pdf

Logs

warning The EntityCommonStockSharesOutstanding does not exist industry.us_generic {}
warning Missing logo subcommand.report {}

Graph

Absolute values for 0000003116, Akorn INC

  xvar xval
0 AssetsCurrent 480,047,000
1 IntangibleAssetsNetIncludingGoodwill 483,724,000
2 PropertyPlantAndEquipmentNet 295,533,000
3 remainder_Assets 29,335,000
4 LiabilitiesCurrent 985,587,000
5 LiabilitiesNoncurrent 68,760,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 406,147,301
8 SellingGeneralAndAdministrativeExpense 266,866,949
9 ResearchAndDevelopmentExpense 39,230,745
10 remainder_Expenses 208,599,727
11 remainder_Revenues 669,421,177
12 remainder_NetIncome -72,399,745
13 remainder_ComprehensiveNetIncome -6,461,519
  yvar yval
0 Assets 1,288,639,000
1 Liabilities 1,054,347,000
2 Expenses 920,844,722
3 Revenues 669,421,177
4 StockholdersEquity 234,292,000
5 NetIncome -323,823,290
6 ComprehensiveNetIncome -327,054,050
7 BaseVar 2,006,056,582
8 EconomicCapitalRatiobeforeLimitedLiability 0.157
9 EconomicCapitalRatio 1.56

Edgar->Model Mapping

Feature Distribution

Change over Time